Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

36 results about "P-methylacetophenone" patented technology

4-Methyl Acetophenone is a natural-identical substance with aromatic, sweet, vanilla, and cumin olfactory notes as well as sweet, citrus, fruity, and cherry tastes. It is a colorless, pale yellow liquid that is insoluble in water but soluble in organic solvents.

Preparation method and application of carbonyl hydrogenation catalyst

The invention discloses a preparation method of a carbonyl hydrogenation catalyst. The method comprises the steps of: cooking activated carbon with hydrochloric acid, and performing filtering and washing; cooking the acid treated activated carbon with an alkaline solution, and performing filtering and washing; cooking the alkali treated activated carbon with an oxidizing agent solution, and performing filtering and washing; adding the activated carbon subjected to oxidation treatment into a modifier solution, and performing stirring to obtain a modified activated carbon slurry; mixing a palladium chloride solution with a copper salt solution, adding the mixed solution of palladium chloride and copper salt into the activated carbon slurry, and performing stirring to obtain a loaded palladium-copper suspension precursor; and reducing the loaded palladium-copper suspension precursor, and conducting filtering, washing and centrifugal drying to obtain the carbonyl hydrogenation catalyst. Inaddition, the invention also provides application of the carbonyl hydrogenation catalyst prepared by the above method in the hydrogenation reaction of p-methylacetophenone. The preparation method provided by the invention is simple, and the carbonyl hydrogenation catalyst prepared by the method has high catalytic activity in the hydrogenation reaction of p-methylacetophenone.
Owner:XIAN CATALYST NEW MATERIALS CO LTD

Method for preparing celecoxib by using one-pot method

The invention discloses a method for preparing celecoxib by using a one-pot method. The method comprises the following steps: in the presence of ethidene diamine, mixing p-methylacetophenone and ethyltrifluoroacetate, and enabling the components to react completely at 40-80 DEG C without other solvent so as to obtain a reaction liquid of an intermediate DO; putting the reaction liquid into an alcohol solvent, further adding bihydrazino-benzsulfamide hydrochloride, further adding an organic acid to adjust the pH value to 3-6, controlling the temperature of a material liquid to 50-80 DEG C, andenabling the components to react completely; after the reaction is completed, adding water, cooling to 10-30 DEG C to separate out a crystal, and carrying out suction filtration so as to obtain a crude product of celecoxib; dissolving the crude product with methanol, dropping the material liquid into water, controlling the temperature of the material liquid to 40-50 DEG C in the dropping process,cooling to 10-30 DEG C to separate out a crystal after dropping is completed, and carrying out suction filtration, thereby obtaining a finished product of celecoxib. The total yield of the product prepared by using the method is greater than 85%, and HPLC (High Performance Liquid Chromatography) tests show that the purity of the product is greater than or equal to 99.90%.
Owner:山东安信制药有限公司

Synthetic method of celecoxib

The invention discloses a synthetic method of celecoxib. The synthetic method is characterized by comprising the following steps: firstly, adding sodium methylate as an aldol condensation catalyst and methylbenzene as a reaction solvent into a reaction container, adding p-methylacetophenone and trifluoroacetic acid ethyl ester, fully reacting, adding diluted hydrochloric acid, and separating out a water layer to obtain a methylbenzene solution of an intermediate-diketone; secondly, adding water, a phase transfer catalyst and 4-aminosulfophenyl hydrazine hydrochloride into the methylbenzene solution of the intermediate-diketone, and performing dehydration cyclization reaction to obtain a celecoxib reaction solution; thirdly, replenishing methylbenzene, standing, separating out the water layer and remaining an organic layer; cooling the organic layer, preserving heat and crystallizing to obtain a crystal product, and performing suction filtration, methylbenzene washing and water washing in sequence to obtain a celecoxib crude product; drying the crude product in vacuum, decolorizing and re-crystallizing to obtain a celecoxib raw material. According to the synthetic method, the celecoxib yield is increased, the reaction time is shortened, the celecoxib purity is high, the three-waste discharge in the whole production process is reduced, and the production cost is low.
Owner:SUZHOU TIANMA SPECIALTY CHEM

One-pot method for preparing celecoxib

The invention discloses a method for preparing celecoxib by using a one-pot method. The method comprises the following steps: in the presence of ethidene diamine, mixing p-methylacetophenone and ethyltrifluoroacetate, and enabling the components to react completely at 40-80 DEG C without other solvent so as to obtain a reaction liquid of an intermediate DO; putting the reaction liquid into an alcohol solvent, further adding bihydrazino-benzsulfamide hydrochloride, further adding an organic acid to adjust the pH value to 3-6, controlling the temperature of a material liquid to 50-80 DEG C, andenabling the components to react completely; after the reaction is completed, adding water, cooling to 10-30 DEG C to separate out a crystal, and carrying out suction filtration so as to obtain a crude product of celecoxib; dissolving the crude product with methanol, dropping the material liquid into water, controlling the temperature of the material liquid to 40-50 DEG C in the dropping process,cooling to 10-30 DEG C to separate out a crystal after dropping is completed, and carrying out suction filtration, thereby obtaining a finished product of celecoxib. The total yield of the product prepared by using the method is greater than 85%, and HPLC (High Performance Liquid Chromatography) tests show that the purity of the product is greater than or equal to 99.90%.
Owner:山东安信制药有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products